|
|
| Line 7: |
Line 7: |
| ==Drug Class== | | ==Drug Class== |
|
| |
|
| Proton Pump Inhibitors (PPI) | | Proton Pump Inhibitors (PPI) |
| | |
| ==Common Strengths of Dexlansoprazole capsule==
| |
| | |
| Dexlansoprazole capsule are available in the following strengths:
| |
| | |
| *30 mg delayed-release capsules
| |
| | |
| *60mg delayed-release capsules
| |
| | |
| ==Drug Trade Names of Dexlansoprazole capsule==
| |
| | |
| Dexilant
| |
| | |
| ==Drug Usage==
| |
| | |
| Dexlansoprazole is used for:
| |
| | |
| *Healing of erosive esophagitis (EE)
| |
| | |
| *Maintenance of healed erosive esophagitis (EE)
| |
| | |
| *Treatment of gastroesophageal reflux disease (GERD)
| |
| | |
| ==Mechanism of Action==
| |
| | |
| Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach
| |
| | |
| ==Route of Administration==
| |
| | |
| Oral
| |
| | |
| ==Dosages ==
| |
| | |
| For adults and children aged 12 years and older, the typical dosage is:
| |
| | |
| Healing: 60 mg once daily for up to 8 weeks
| |
| | |
| Maintenance: 30 mg once daily for up to 6 months
| |
| | |
| GERD: 30 mg once daily for up to 4 weeks
| |
| | |
| ==Renal Dose Adjustments==
| |
| | |
| No renal dose adjustment recommended
| |
| | |
| ==Side Effects==
| |
Revision as of 02:24, 6 January 2025
Gastrointestinal Drug
Drug class: Proton Pump Inhibitors (PPI)
Dexlansoprazole (中文: 右蘭索拉唑)
Drug Class
Proton Pump Inhibitors (PPI)
